ketamine
Pre-clinical- Indications
- Parkinson's disease, Depression, Pain
Company intelligence / Profile preview
PharmaTher Holdings Ltd.
Toronto, Ontario, Canada
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
PharmaTher has submitted a New Drug Application to the FDA for KETARX™ ketamine and expects potential approval in Q2–2025. The company has completed stability and manufacturing requirements with no new preclinical or clinical studies requested by the FDA. It also owns a stake in Sairiyo Therapeutics developing an oral cepharanthine product in clinical stages.[7]
Clinical results to date support safety and efficacy of ketamine for anesthesia, pain, and mental health uses; additional programs are at various research or early clinical stages.
The company commercializes through partnerships such as with Vitruvias Therapeutics in the U.S.[8]
- Therapeutic areas
- OtherPsychiatryNeurologyInfectious Diseases
- Modalities
- Small molecules (notably ketamine, cepharanthine)Drug delivery technologies (microneedle patch, oral formulations)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Vitruvias Therapeutics Inc. – U.S. commercialization partner for KETARX™ racemic ketamine products[8]
Beyond the preview
Go deeper on PharmaTher Holdings Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmaTher Holdings Ltd..